Centro Español de Investigación Farmacoepidemiológica

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. Bayer (Germany)德国8
2. Utrecht University荷兰5
3. Universidad de Alcalá西班牙5
4. Pfizer (United States)美国5
5. Agencia Española de Medicamentos y Productos Sanitarios西班牙4
6. Leibniz Institute for Prevention Research and Epidemiology - BIPS德国4
7. Universidad Complutense de Madrid西班牙4
8. Pfizer (United Kingdom)英国4

按月发文

逐年被引

最新文献

1. 1
   Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countriesExpert Opinion on Drug Safety20231
2. 2
   Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic strokePharmacoepidemiology and Drug Safety20221
3. 3
   Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of PrucaloprideDrug Safety20211
4. 4
   Use of non‐vitamin K antagonist oral anticoagulants in Colombia: A descriptive study using a national administrative healthcare databasePharmacoepidemiology and Drug Safety20206
5. 5
   Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement NetworkPharmacoepidemiology and Drug Safety20206
6. 6
   Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practiceExpert Opinion on Drug Safety20207
7. 7
   No association between use of phosphodiesterase 5 inhibitors and colorectal cancer in men with erectile dysfunctionPharmacoepidemiology and Drug Safety20205
8. 8
   Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350Drug Safety20193
9. 9
   Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort StudyDrug Safety201930
10. 10
    Validation study of colorectal cancer diagnosis in the Spanish primary care database, BIFAPPharmacoepidemiology and Drug Safety201817

高被引文献

1. 1
   Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross‐national descriptive study from the PROTECT‐EU ProjectPharmacoepidemiology and Drug Safety2015130
2. 2
   Prevalence of antibiotic use: a comparison across various European health care data sourcesPharmacoepidemiology and Drug Safety201557
3. 3
   Validation of low‐dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over‐the‐counter use?Pharmacoepidemiology and Drug Safety201539
4. 4
   Subdural hematoma cases identified through a Danish patient register: diagnosis validity, clinical characteristics, and preadmission antithrombotic drug usePharmacoepidemiology and Drug Safety201635
5. 5
   Validity and completeness of colorectal cancer diagnoses in a primary care database in the United KingdomPharmacoepidemiology and Drug Safety201532
6. 6
   Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort StudyDrug Safety201930
7. 7
   Validation study of colorectal cancer diagnosis in the Spanish primary care database, BIFAPPharmacoepidemiology and Drug Safety201817
8. 8
   Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case–control studies using two primary care databases in EuropePharmacoepidemiology and Drug Safety201617
9. 9
   Do case‐only designs yield consistent results across design and different databases? A case study of hip fractures and benzodiazepinesPharmacoepidemiology and Drug Safety201514
10. 10
    Ascertainment and validation of major bleeding events in a primary care databasePharmacoepidemiology and Drug Safety201812

主要发表期刊